195 related articles for article (PubMed ID: 19731855)
1. Clinical applications of 18F-fluorodeoxyglucose positron emission tomography in gastrointestinal stromal tumor of the esophagus.
Sakai M; Kato H; Saito K; Tanaka N; Inose T; Kimura H; Miyazaki T; Kuwano H
Int Surg; 2008; 93(4):209-13. PubMed ID: 19731855
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stromal tumor (GIST) of the esophagus detected by positron emission tomography/computed tomography.
Chang WC; Tzao C; Shen DH; Cheng CY; Yu CP; Hsu HH
Dig Dis Sci; 2005 Jul; 50(7):1315-8. PubMed ID: 16047479
[No Abstract] [Full Text] [Related]
3. Imaging and clinicopathologic features of esophageal gastrointestinal stromal tumors.
Winant AJ; Gollub MJ; Shia J; Antonescu C; Bains MS; Levine MS
AJR Am J Roentgenol; 2014 Aug; 203(2):306-14. PubMed ID: 25055264
[TBL] [Abstract][Full Text] [Related]
4. Preoperative assessment of malignant potential of gastrointestinal stromal tumor by dual-time-point 18F-fluorodeoxyglucose positron emission tomography imaging: Usefulness of standardized uptake value and retention index.
Kwon Y; Park E; Pahk K; Kim S; Kim MJ; Graf D; Park S
J Cancer Res Ther; 2019; 15(1):142-147. PubMed ID: 30880770
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors.
Kamiyama Y; Aihara R; Nakabayashi T; Mochiki E; Asao T; Kuwano H; Oriuchi N; Endo K
World J Surg; 2005 Nov; 29(11):1429-35. PubMed ID: 16222452
[TBL] [Abstract][Full Text] [Related]
6. Esophageal gastrointestinal stromal tumor: report of 7 patients.
Shinagare AB; Zukotynski KA; Krajewski KM; Jagannathan JP; Butrynski J; Hornick JL; Ramaiya NH
Cancer Imaging; 2012 Apr; 12(1):100-8. PubMed ID: 22542728
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J
Oncology; 2005; 69(4):326-32. PubMed ID: 16293972
[TBL] [Abstract][Full Text] [Related]
8. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
Miettinen M; Wang ZF; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
[TBL] [Abstract][Full Text] [Related]
9. Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.
Prior JO; Montemurro M; Orcurto MV; Michielin O; Luthi F; Benhattar J; Guillou L; Elsig V; Stupp R; Delaloye AB; Leyvraz S
J Clin Oncol; 2009 Jan; 27(3):439-45. PubMed ID: 19064982
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of preoperative
Miyake KK; Nakamoto Y; Mikami Y; Tanaka S; Higashi T; Tadamura E; Saga T; Minami S; Togashi K
Eur Radiol; 2016 Dec; 26(12):4664-4674. PubMed ID: 26852217
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic Features and Molecular Characteristics of Glucose Metabolism Contributing to ¹⁸F-fluorodeoxyglucose Uptake in Gastrointestinal Stromal Tumors.
Cho MH; Park CK; Park M; Kim WK; Cho A; Kim H
PLoS One; 2015; 10(10):e0141413. PubMed ID: 26509967
[TBL] [Abstract][Full Text] [Related]
12. Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography.
Heinicke T; Wardelmann E; Sauerbruch T; Tschampa HJ; Glasmacher A; Palmedo H
Anticancer Res; 2005; 25(6C):4591-4. PubMed ID: 16334147
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography image on evaluating intraperitoneal dissemination of malignant gastrointestinal stromal tumor.
Kobayashi Y; Nakao M; Konishi M; Urawa N; Iwasa M; Kaito M; Adachi Y
Hepatogastroenterology; 2008; 55(84):895-7. PubMed ID: 18705291
[TBL] [Abstract][Full Text] [Related]
14. An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development.
Cullinane C; Dorow DS; Kansara M; Conus N; Binns D; Hicks RJ; Ashman LK; McArthur GA; Thomas DM
Cancer Res; 2005 Nov; 65(21):9633-6. PubMed ID: 16266981
[TBL] [Abstract][Full Text] [Related]
15. A case of carcinosarcoma of the esophagus detected on fluorodeoxyglucose positron emission tomography.
Matsutani T; Nomura T; Hagiwara N; Yoshida H; Yokoyama T; Katayama H; Hosone M; Matsuda A; Uchida E
J Nippon Med Sch; 2014; 81(6):401-5. PubMed ID: 25744486
[TBL] [Abstract][Full Text] [Related]
16. The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors.
Tokumoto N; Tanabe K; Misumi T; Fujikuni N; Suzuki T; Ohdan H
Dig Surg; 2014; 31(2):79-86. PubMed ID: 24776690
[TBL] [Abstract][Full Text] [Related]
17. Is FDG-PET indicated for superficial esophageal cancer?
Little SG; Rice TW; Bybel B; Mason DP; Murthy SC; Falk GW; Rybicki LA; Blackstone EH
Eur J Cardiothorac Surg; 2007 May; 31(5):791-6. PubMed ID: 17337344
[TBL] [Abstract][Full Text] [Related]
18. "Seedling" mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction.
Abraham SC; Krasinskas AM; Hofstetter WL; Swisher SG; Wu TT
Am J Surg Pathol; 2007 Nov; 31(11):1629-35. PubMed ID: 18059218
[TBL] [Abstract][Full Text] [Related]
19. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
20. Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to
Van Weehaeghe D; Gheysens O; Vandecaveye V; Schöffski P; Van Laere K; Deroose CM
BMC Cancer; 2018 Mar; 18(1):253. PubMed ID: 29506493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
